Leland Gershell

Leland Gershell

Analyst-Equity at
Oppenheimer & Co., Inc. (Broker)
54 year
Finance
Health Technology
Consumer Services

Profile

Dr. Leland Gershell is a Managing Director & Senior Analyst at Oppenheimer & Co., Inc. He covers BioPharmaceuticals.
Prior to joining Oppenheimer, Dr. Gershell was Chief Financial Officer of Capricor Therapeutics and Tonix Pharmaceuticals.
He also has both sell-side and buy-side experience and began his career on Cowen's biotechnology research team, where he provided sole coverage focused in the small and mid-cap segment.
Dr. Gershell earned his M.D.
and Ph.D.
in Organic Chemistry from Columbia University and his B.A. magna cum laude in Chemistry and Asian Studies from Dartmouth College.

Leland Gershell active positions

CompaniesPositionStart
Analyst-Equity 01/02/2018

Former positions of Leland Gershell

CompaniesPositionEnd
CAPRICOR THERAPEUTICS, INC. Director of Finance/CFO 01/01/2018
TONIX PHARMACEUTICALS HOLDING CORP. Director of Finance/CFO 08/01/2016
Analyst-Equity 31/03/2012
Corporate Officer/Principal 01/10/2010
Analyst-Equity 31/05/2010
See the detail of Leland Gershell's experience

Training of Leland Gershell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Health Technology

Finance

Finance

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Leland Gershell